Krebs Biochemicals and Industries Ltd Q1FY24 loss at Rs. 5.33 crore

Krebs Biochemicals and Industries Limited has reported Standalone financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 10.6188 crores during the period ended June 30, 2023 as compared to Rs. 11.6538 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. -5.3329 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. -6.9397 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. -2.47 for the period ended June 30, 2023 as compared to Rs. -3.07 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 10.6188 crs	₹11.6538 crs	-8.88%
Net Profit	₹-5.3329 crs	₹-6.9397 crs	23.15%
EPS	₹-2.47	₹-3.07	19.54%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 10.6188 crores during the period ended June 30, 2023 as compared to Rs.10.7699 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.-5.3329 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.-8.1367 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.-2.47 for the period ended June 30, 2023 as compared to Rs.-3.77 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 10.6188 crs	₹10.7699 crs	-1.40%
Net Profit	₹-5.3329 crs	₹-8.1367 crs	34.46%
EPS	₹-2.47	₹-3.77	34.48%

Shares of Krebs Biochemicals and Industries Limited was last trading in BSE at Rs. 71.50 as compared to the previous close of Rs. 70.76. The total number of shares traded during the day was 604 in over 7 trades.

The stock hit an intraday high of Rs. 71.50 and intraday low of 69.91. The net turnover during the day was Rs. 43022.00.

Source : Equity Bulls

Keywords

KrebsBiochemicalsandIndustries Q1FY24 ResultUpdate